For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News

BREAKING NEWS
Nikhil Prasad  Fact checked by:Thailand Medical News Team Aug 04, 2024  3 months, 1 week, 3 days, 6 hours, 32 minutes ago

Phytochemicals as potential saviors against COVID-19-associated sepsis

3127 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
Phytochemicals as potential saviors against COVID-19-associated sepsis
Nikhil Prasad  Fact checked by:Thailand Medical News Team Aug 04, 2024  3 months, 1 week, 3 days, 6 hours, 32 minutes ago
Sepsis: COVID-19 has had a staggering global impact, with millions affected and a broad spectrum of symptoms ranging from mild respiratory issues to severe pneumonia and acute respiratory distress syndrome (ARDS). One of the critical complications that have emerged is COVID-19-associated sepsis, a life-threatening condition that disrupts the normal function of multiple organ systems, leading to increased morbidity and mortality.


Phytochemicals as potential saviors against COVID-19-associated sepsis

The Crisis of COVID-19-Associated Sepsis
Sepsis, in general, is a severe and life-threatening response to infection, leading to organ dysfunction and failure. With COVID-19, this condition becomes even more critical. This article explores the devastating impact of sepsis in COVID-19 patients and highlights potential therapeutic interventions, particularly the use of phytochemicals found in everyday foods.
 
Researchers from Marshall University, USA, and Sharif Medical and Dental College, Pakistan, have reviewed the potential role of phytochemicals - bioactive compounds found in plants - in combating COVID-19-associated sepsis. These compounds, commonly found in fruits, vegetables, and other plant-based foods, are known for their anti-inflammatory, antioxidant, and immunomodulatory properties.
 
The Inflammatory Cascade
The pathogenesis of COVID-19-associated sepsis involves a complex interplay between the virus and the host's immune system. SARS-CoV-2, the virus responsible for COVID-19, triggers an overactive immune response, leading to a hyper-inflammatory condition known as a cytokine storm. This overreaction results in widespread tissue damage and organ dysfunction.
 
Phytochemicals, due to their natural anti-inflammatory properties, offer a promising adjunctive treatment to mitigate this inflammatory response. The key phytochemicals explored in this study include quercetin, curcumin, luteolin, apigenin, resveratrol, and naringenin - compounds found in foods like citrus fruits, onions, turmeric, and grapes.
 
The Power of Phytochemicals
-Quercetin, a flavonoid found in many fruits and vegetables, has shown potential in reducing inflammation and oxidative stress. Studies have demonstrated its ability to modulate immune responses, making it a candidate for treating inflammatory conditions like sepsis.
 
-Curcumin, the active compound in turmeric, is renowned for its anti-inflammatory and antioxidant effects. It has been shown to reduce the severity of sepsis by modulating various inflammatory pathways and improving mitochondrial function.
 
-Luteolin and apigenin, found in celery, parsley, and chamomile, have also demonstrated anti-inflammatory properties. These compounds can inhibit the production of pro-inflammatory cytokines and reduce oxidative stress, contributing to better outcomes in sepsis.
 
-Resveratrol ;, present in grapes and red wine, offers protective effects against sepsis by reducing oxidative damage and improving mitochondrial function. Its anti-inflammatory properties further enhance its potential as a therapeutic agent.

-Naringenin, found in citrus fruits, has shown promise in reducing inflammation and oxidative stress. Its ability to modulate immune responses makes it a valuable compound in the fight against COVID-19-associated sepsis.
 
Current Treatment Approaches and Challenges
The treatment of COVID-19-associated sepsis involves various strategies, including corticosteroids, immunotherapy, and anticoagulants. Corticosteroids like dexamethasone have shown effectiveness in reducing mortality among severe COVID-19 patients by suppressing the cytokine storm. Immunotherapy agents like anakinra and tocilizumab help manage the excessive inflammatory response characteristic of sepsis.
 
Despite these advancements, the management of COVID-19-associated sepsis remains challenging. The heterogeneity of sepsis presentations and the rapid progression of symptoms demand timely and aggressive intervention. Moreover, the use of these therapies carries risks of secondary infections and other adverse effects, necessitating careful risk–benefit analyses.
 
Phytochemicals: A Promising Adjunctive Therapy
Given the challenges in treating COVID-19-associated sepsis, the incorporation of phytochemicals as functional foods and nutraceuticals offers a promising adjunctive strategy. These compounds provide dual benefits: nutritional value and therapeutic potential, making them viable additions to conventional treatments.
 
Phytochemicals like quercetin, curcumin, luteolin, apigenin, resveratrol, and naringenin have demonstrated significant potential in modulating inflammation, reducing oxidative stress, and improving immune responses. These properties are critical in managing the inflammatory and oxidative damage associated with sepsis.
 
Future Directions and Conclusion
The therapeutic potential of phytochemicals in treating COVID-19-associated sepsis warrants further research. Clinical trials are necessary to validate their efficacy and safety, paving the way for their integration into treatment protocols. The incorporation of these natural compounds could revolutionize the management of sepsis, offering a safer and more affordable alternative to synthetic drugs.
 
In conclusion, the study highlights the promising role of phytochemicals in combating COVID-19-associated sepsis. Their natural anti-inflammatory, antioxidant, and immunomodulatory properties make them valuable adjunctive therapies. Continued research and clinical trials will be essential in validating their potential and integrating them into standard treatment protocols.
 
The study findings were published in the peer-reviewed International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/25/15/8481
 
For the latest on Sepsis, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/reduced-plasma-bmp6-levels-in-sepsis-new-insights-into-iron-regulation
 
https://www.thailandmedical.news/news/l-valine-from-gut-microbiota-helps-fight-sepsis

MOST READ

Nov 05, 2024  9 days ago
Nikhil Prasad
Jul 25, 2024  4 months ago
Nikhil Prasad
Jul 24, 2024  4 months ago
Nikhil Prasad
Jun 10, 2023  1 year ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer